In this session you’ll see facility strategies for accelerating speed to market, integrating emerging technologies, better equipping the biopharmaceutical and biomanufacturing workforce, and delivering space to attract industry partners. Session leaders examine today’s regulatory compliance and scalability drivers that are driving facility design decisions, and they identify best practices for developing “GMP-like” environments, advancing new bio therapies for commercial and clinical translation, attracting and retaining talent, leveraging partner capabilities, and linking research to manufacturing readiness. They profile the facility infrastructure Georgia Tech is putting in place to establish a leadership position in healthcare innovation, precision medicine, biomanufacturing, and value-based healthcare delivery.